Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort studyHilde S Ørbo, Kristin H Bjørlykke, Joseph Sexton, Ingrid Jyssum, Anne T Tveter, Ingrid E Christensen, Siri Mjaaland, Tore K Kvien, Gunnveig Grødeland, Grete B Kro, Jørgen Jahnsen, Espen A Haavardsholm, Ludvig A Munthe, Sella A Provan, John T VaageSee the full list of authors
9 April 2024
COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary seriesInes Colmegna, Valeria Valerio, Nathalie Amiable, Mariana Useche, Emmanouil Rampakakis, Louis Flamand, Emmanuelle Rollet-Labelle, Louis Bessette, Mary-Ann Fitzcharles, Elizabeth Hazel, Deirdre McCormack, Laëtitia Michou, Pantelis Panopalis, Marc-André Langlois, Sasha BernatskySee the full list of authors
29 November 2023
COVID-19 infection and efficacy of vaccination in patients with rheumatic diseases during Omicron outbreak in South Korea: a prospective cohort studyYun Kyu Kim, Ju Yeon Kim, Ji In Jung, Jin Kyun Park, Eun Young Lee, Eun-Bong Lee, Jun Won Park
16 November 2023
Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort studyMichaela Koehm, Maximilian Klippstein, Stephanie Dauth, Konstantin Hallmann, Niko Kohmer, Harald Burkhardt, Sandra Ciesek, Gerd Geisslinger, Holger F Rabenau, Frank Behrens
31 August 2023
Outcomes of COVID-19 in patients with ANCA-associated vasculitis receiving avacopanFaten Aqeel, Reza Zonozi, Anushya Jeyabalan, Gabriel Sauvage, John L Niles, Duvuru Geetha
28 August 2023
Risk factors for severe COVID-19 among patients with systemic lupus erythematosus: a real-world analysis of a large representative US administrative claims database, 2020–2021Cassandra Calabrese, Gelareh Atefi, Kristin A Evans, Meghan Moynihan, Liisa Palmer, Sze-Jung Wu
17 August 2023
COVID-19 outcomes in patients with rheumatoid arthritis with biologic or targeted synthetic DMARDsJih-Jin Tsai, Li-Teh Liu, Chun-Hong Chen, Liang-Jen Chen, Shiow-Ing Wang, James Cheng-Chung Wei
21 July 2023
Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD groupFrancesco Ursini, Piero Ruscitti, Olga Addimanda, Rosario Foti, Vincenzo Raimondo, Giuseppe Murdaca, Virginia Caira, Erika Pigatto, Giovanna Cuomo, Alberto Lo Gullo, Ilaria Cavazzana, Corrado Campochiaro, Caterina Naclerio, Rossella De Angelis, Jacopo CiaffiSee the full list of authors
16 June 2023
Self-evidence-based digital care programme improves health-related quality of life in adults with a variety of autoimmune diseases and long COVID: a retrospective studyNicole Bundy, Mackenzie De Jesus, Millennia Lytle, Leonard Calabrese, Christina Gobin, Mette Dyhrberg
16 May 2023
Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseasesRebecca Hasseli, Jutta G. Richter, Bimba Franziska Hoyer, Hanns-Martin Lorenz, Alexander Pfeil, Anne Constanze Regierer, Tim Schmeiser, Anja Strangfeld, Reinhard E Voll, Andreas Krause, Sabine Reckert, Anett Gräßler, Petra Saar, Andreas Kapelle, Marina BackhausSee the full list of authors
17 April 2023
